📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Standard Bariatrics

1.1 - Company Overview

Standard Bariatrics Logo

Standard Bariatrics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of surgical instruments for weight-loss surgeries, focused on sleeve gastrectomy. Offerings include Titan SGS, a surgical stapler with a 23 cm continuous staple line for consistent sleeve anatomy; Standard Precision Bougie Device for precise alignment and protection of the incisura angularis; Standard Trocar, a bladeless access device for introducing Titan SGS; and Standard Clamp to plan and hold the staple line, helping standardize technique and improve efficiency.

Products and services

  • Titan SGS: Sleeve-gastrectomy-specific surgical stapler engineered to deliver a 23cm continuous staple line, supporting consistent sleeve anatomy during sleeve gastrectomy
  • Standard Clamp: Laparoscopic device that clamps the entire stomach length to aid planning and hold the staple line before division, helping standardize techniques, reduce variation, improve efficiency, and eliminate waste
  • Standard Precision Bougie Device: Sleeve-gastrectomy-specific component architects precise anatomical alignment and protects the incisura angularis, assisting surgeons in maintaining accurate sleeve anatomy during the procedure

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Standard Bariatrics

Calliditas Therapeutics Logo

Calliditas Therapeutics

HQ: Sweden Website
  • Description: Provider of specialty pharmaceuticals for unmet medical needs in niche indications, including TARPEYO (delayed-release budesonide for renal diseases), Kinpeygo (renal and hepatic diseases), NEFECON (candidate for primary IgA nephropathy), and Setanaxib (NOX1/4 inhibitor in trials for PBC and head & neck cancer), plus pipeline development for orphan renal/hepatic diseases and strategic partnerships for development and commercialization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Calliditas Therapeutics company profile →
QOL Medical Logo

QOL Medical

HQ: United States Website
  • Description: Provider of specialty biopharmaceutical products and services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full QOL Medical company profile →
Baronova Logo

Baronova

HQ: United States Website
  • Description: Provider of clinical-stage medical devices under development to induce weight loss through non-surgical, non-pharmacologic approaches.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Baronova company profile →
Theratechnologies Logo

Theratechnologies

HQ: Canada Website
  • Description: Provider of biopharmaceutical therapies, including Trogarzo for HIV in individuals with limited treatment options due to resistance, intolerance, or safety considerations; EGRIFTA SV (tesamorelin) to reduce excess abdominal fat in HIV patients with lipodystrophy; and Long Acting Peptides and the SORT1+ oncology platform. Pipeline includes tesamorelin for NASH, F8 bioequivalent formulation, and a multi-dose pen injector in development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Theratechnologies company profile →
XOMA Logo

XOMA

HQ: United States Website
  • Description: Provider of biotech royalty aggregation through acquiring economic rights to future milestone and royalty payments from pre-commercial clinical candidates and commercial therapies, supported by a royalty portfolio of licenses; also provider of antibody discovery and development via a phage display platform, with developing assets including ebopiprant and an anti-prolactin antibody.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full XOMA company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Standard Bariatrics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Standard Bariatrics

2.2 - Growth funds investing in similar companies to Standard Bariatrics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Standard Bariatrics

4.2 - Public trading comparable groups for Standard Bariatrics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Standard Bariatrics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Standard Bariatrics

What does Standard Bariatrics do?

Standard Bariatrics is a provider of surgical instruments for weight-loss surgeries, focused on sleeve gastrectomy. Offerings include Titan SGS, a surgical stapler with a 23 cm continuous staple line for consistent sleeve anatomy; Standard Precision Bougie Device for precise alignment and protection of the incisura angularis; Standard Trocar, a bladeless access device for introducing Titan SGS; and Standard Clamp to plan and hold the staple line, helping standardize technique and improve efficiency.

Who are Standard Bariatrics's competitors?

Standard Bariatrics's competitors and similar companies include Calliditas Therapeutics, QOL Medical, Baronova, Theratechnologies, and XOMA.

Where is Standard Bariatrics headquartered?

Standard Bariatrics is headquartered in United States.

How many employees does Standard Bariatrics have?

Standard Bariatrics has 1,000 employees 🔒.

When was Standard Bariatrics founded?

Standard Bariatrics was founded in 2010 🔒.

What sector and industry vertical is Standard Bariatrics in?

Standard Bariatrics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Standard Bariatrics

Who are the top strategic acquirers in Standard Bariatrics's sector and industry

Top strategic M&A buyers and acquirers in Standard Bariatrics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Standard Bariatrics?

Top strategic M&A buyers groups and sectors for Standard Bariatrics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Standard Bariatrics's sector and industry vertical

Which are the top PE firms investing in Standard Bariatrics's sector and industry vertical?

Top PE firms investing in Standard Bariatrics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Standard Bariatrics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Standard Bariatrics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Standard Bariatrics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Standard Bariatrics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Standard Bariatrics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Standard Bariatrics?

The key public trading comparables and valuation benchmarks for Standard Bariatrics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Standard Bariatrics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Standard Bariatrics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Standard Bariatrics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Standard Bariatrics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Standard Bariatrics's' sector and industry vertical?

Access recent funding rounds and capital raises in Standard Bariatrics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Standard Bariatrics

Launch login modal Launch register modal